| Maria Belen Game, MD | |
|
2500 E Commercial Blvd Ste D, Fort Lauderdale, FL 33308 | |
| (954) 909-5708 | |
| (954) 909-5709 |
| Full Name | Maria Belen Game |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Experience | 27 Years |
| Location | 2500 E Commercial Blvd Ste D, Fort Lauderdale, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801098926 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | ME116126 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Cross Hospital | Fort lauderdale, FL | Hospital |
| Broward Health Imperial Point | Fort lauderdale, FL | Hospital |
| Entity Name | Pronto Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003353020 PECOS PAC ID: 3476814930 Enrollment ID: O20180223001589 |
News Archive
Helix BioMedix, Inc., a developer of bioactive peptides, announced that the Company entered into an agreement with RubyDerm Bio, Inc. under which RubyDerm will assume responsibility, on an exclusive basis, for the distribution of certain of Helix BioMedix's branded prestige skin care products to spas, beauty stores, hospitals, clinics, physicians, and consumers in South Korea, China and Japan.
A new study reveals that in the prediction of treatment outcome for castration-resistant prostate cancer, a change in circulating tumour cells detection might be more accurate than the change in prostate-specific antigen levels. The findings of this award-winning study were presented at the recent EAU 13th Central European Meeting in Prague.
Drug discovery company SCYNEXIS, Inc. today presented data supporting an impressive resistance profile for SCY-635—a novel, oral cyclophilin inhibitor being studied for the treatment of hepatitis C virus (HCV) infection. In the study, SCYNEXIS demonstrated that the hepatitis C virus required multiple mutations across two separate proteins in order to establish resistance to SCY-635. The majority of HCV drugs on the market and in development require only one targeted viral mutation to establish resistance.
Many people admitted to hospitals in the U.S. have alcohol use disorders that go undetected, according to a new study by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), one of the National Institutes of Health (NIH).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Belen Game, MD 2500 E Commercial Blvd Ste D, Fort Lauderdale, FL 33308-4124 Ph: (954) 909-5709 | Maria Belen Game, MD 2500 E Commercial Blvd Ste D, Fort Lauderdale, FL 33308 Ph: (954) 909-5708 |
News Archive
Helix BioMedix, Inc., a developer of bioactive peptides, announced that the Company entered into an agreement with RubyDerm Bio, Inc. under which RubyDerm will assume responsibility, on an exclusive basis, for the distribution of certain of Helix BioMedix's branded prestige skin care products to spas, beauty stores, hospitals, clinics, physicians, and consumers in South Korea, China and Japan.
A new study reveals that in the prediction of treatment outcome for castration-resistant prostate cancer, a change in circulating tumour cells detection might be more accurate than the change in prostate-specific antigen levels. The findings of this award-winning study were presented at the recent EAU 13th Central European Meeting in Prague.
Drug discovery company SCYNEXIS, Inc. today presented data supporting an impressive resistance profile for SCY-635—a novel, oral cyclophilin inhibitor being studied for the treatment of hepatitis C virus (HCV) infection. In the study, SCYNEXIS demonstrated that the hepatitis C virus required multiple mutations across two separate proteins in order to establish resistance to SCY-635. The majority of HCV drugs on the market and in development require only one targeted viral mutation to establish resistance.
Many people admitted to hospitals in the U.S. have alcohol use disorders that go undetected, according to a new study by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), one of the National Institutes of Health (NIH).
› Verified 5 days ago
Mr. Wesley Paul, General Practice Medicare: Not Enrolled in Medicare Practice Location: 1809 Ne 59th St, Fort Lauderdale, FL 33308 Phone: 754-366-7735 | |
Jones Cemelus, M.D General Practice Medicare: Medicare Enrolled Practice Location: 3880 W Broward Blvd, Fort Lauderdale, FL 33312 Phone: 954-644-8902 | |
Dr. David Arnold Tillman, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1585 S Ocean Ln, #280, Fort Lauderdale, FL 33316 Phone: 954-900-3903 | |
Alix Simone Ferdinand, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 4725 N Federal Hwy, Fort Lauderdale, FL 33308 Phone: 954-938-3359 | |
Harry Serfer, General Practice Medicare: Not Enrolled in Medicare Practice Location: 2510 E Oakland Park Blvd, Fort Lauderdale, FL 33306 Phone: 954-717-1919 Fax: 954-717-2528 | |
Ms. Tara Ann Howard, DO General Practice Medicare: Medicare Enrolled Practice Location: 4725 N Federal Hwy, Fort Lauderdale, FL 33308 Phone: 954-938-3359 Fax: 954-492-5790 | |
Dr. Nicolas Applyrs Jr., DO General Practice Medicare: Accepting Medicare Assignments Practice Location: 3880 W Broward Blvd Ste B4-b9, Fort Lauderdale, FL 33312 Phone: 954-644-8902 |